EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond Survival: Integrating Fertility Preservation into Gynaecologic Cancer Management

Christina Pappa, Muhammad Fatum, Haya Nasser, Umniah Khajori, Danielle Christmas, Nouf Khalifeh, Mohammad Daas, Moiad Alazzam

Reproductive Medicine · 13.05.2026 · 7 (2) · 22

DOI: 10.3390/reprodmed7020022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive Medicine, online erschienen am 13.05.2026. Verfasst von Christina Pappa und 7 weiteren Autor:innen. Die Arbeit nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As survival rates among patients with gynaecological cancers continue to improve, fertility preservation has become an increasingly important aspect of comprehensive cancer care, particularly for younger women diagnosed during their reproductive years. The impact of treatment on fertility varies according to cancer type, stage, and modality, necessitating individualised preservation strategies. Fertility preservation is both feasible and safe in carefully selected patients with early-stage gynaecological cancers. Oocyte and embryo cryopreservation remain the most widely accepted techniques, particularly when time allows for ovarian stimulation. Fertility-sparing surgeries, such as radical trachelectomy and conservative management of early endometrial cancer, have shown promising oncological and reproductive outcomes. However, barriers including access, timing, and awareness continue to limit broader implementation. In modern society, fertility-preserving strategies should form an integral part of treatment planning for reproductive-aged women with gynaecological malignancies. Early referral to a fertility specialist, patient-centred counselling, and a coordinated multidisciplinary approach are essential to optimise both oncological and reproductive outcomes. Further research and education are required to refine guidelines and expand access to fertility-preserving care. This review presents the current fertility preservation options available to women with gynaecological cancers, including cervical, ovarian, and endometrial malignancies, and highlights the importance of early multidisciplinary intervention in delivering personalised care.

Zitieren

APA

Pappa, C., Fatum, M., Nasser, H., Khajori, U., Christmas, D., Khalifeh, N., Daas, M., & Alazzam, M. (2026). Beyond Survival: Integrating Fertility Preservation into Gynaecologic Cancer Management. Reproductive Medicine, 7(2), 22. https://doi.org/10.3390/reprodmed7020022

Vancouver

Pappa C, Fatum M, Nasser H, Khajori U, Christmas D, Khalifeh N, et al. Beyond Survival: Integrating Fertility Preservation into Gynaecologic Cancer Management. Reproductive Medicine. 2026;7(2):22. doi:10.3390/reprodmed7020022

BibTeX
@article{Pappa2026,
  author = {Pappa, Christina and Fatum, Muhammad and Nasser, Haya and Khajori, Umniah and Christmas, Danielle and Khalifeh, Nouf and Daas, Mohammad and Alazzam, Moiad},
  title = {Beyond Survival: Integrating Fertility Preservation into Gynaecologic Cancer Management},
  journal = {Reproductive Medicine},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {22},
  doi = {10.3390/reprodmed7020022}
}
Kostenlos starten →